Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)
CNY 24.5
(-0.2%)
CNY 24.5
(-0.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.54 Billion CNY | -8.86% |
| 2022 | 1.69 Billion CNY | 16.83% |
| 2021 | 1.45 Billion CNY | 20.25% |
| 2020 | 1.2 Billion CNY | 302.31% |
| 2019 | 300.18 Million CNY | 0.0% |
| 2018 | - CNY | -100.0% |
| 2017 | 220 Million CNY | 88.85% |
| 2016 | 116.49 Million CNY | -10.39% |
| 2015 | 130 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 3.21 Million CNY | -35.72% |
| 2007 | 5 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.98 Billion CNY | 28.52% |
| 2024 Q3 | 1.78 Billion CNY | -3.67% |
| 2024 Q2 | 1.85 Billion CNY | -6.59% |
| 2023 Q4 | 1.54 Billion CNY | -27.08% |
| 2023 Q3 | 2.12 Billion CNY | 2.33% |
| 2023 Q2 | 2.07 Billion CNY | 14.53% |
| 2023 Q1 | 1.8 Billion CNY | 6.65% |
| 2023 FY | 1.54 Billion CNY | -8.86% |
| 2022 Q2 | 1.48 Billion CNY | 1.47% |
| 2022 Q4 | 1.69 Billion CNY | 16.31% |
| 2022 FY | 1.69 Billion CNY | 16.83% |
| 2022 Q3 | 1.45 Billion CNY | -1.92% |
| 2022 Q1 | 1.46 Billion CNY | 0.93% |
| 2021 Q4 | 1.45 Billion CNY | 15.49% |
| 2021 Q1 | 1.12 Billion CNY | -6.99% |
| 2021 Q2 | 1.38 Billion CNY | 22.95% |
| 2021 Q3 | 1.25 Billion CNY | -8.95% |
| 2021 FY | 1.45 Billion CNY | 20.25% |
| 2020 FY | 1.2 Billion CNY | 302.31% |
| 2020 Q4 | 1.2 Billion CNY | -0.56% |
| 2020 Q2 | 660.33 Million CNY | 64.98% |
| 2020 Q1 | 400.24 Million CNY | 33.33% |
| 2020 Q3 | 1.21 Billion CNY | 83.91% |
| 2019 Q4 | 300.18 Million CNY | 0.06% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 FY | 300.18 Million CNY | 0.0% |
| 2019 Q3 | 300 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 Q3 | 100 Million CNY | -62.26% |
| 2018 Q1 | 265 Million CNY | 20.45% |
| 2018 FY | - CNY | -100.0% |
| 2018 Q4 | - CNY | -100.0% |
| 2018 Q2 | 265 Million CNY | 0.0% |
| 2017 Q3 | 197 Million CNY | 37.76% |
| 2017 Q4 | 220 Million CNY | 11.68% |
| 2017 FY | 220 Million CNY | 88.85% |
| 2017 Q1 | 87.49 Million CNY | -24.89% |
| 2017 Q2 | 143 Million CNY | 63.44% |
| 2016 Q2 | 130 Million CNY | -50.0% |
| 2016 Q1 | 260 Million CNY | 100.0% |
| 2016 FY | 116.49 Million CNY | -10.39% |
| 2016 Q3 | 95 Million CNY | -26.92% |
| 2016 Q4 | 116.49 Million CNY | 22.63% |
| 2015 Q4 | 130 Million CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 130 Million CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2009 FY | - CNY | -100.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2008 Q4 | 3.21 Million CNY | 0.0% |
| 2008 FY | 3.21 Million CNY | -35.72% |
| 2007 FY | 5 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |